Infection News

Pregnant women who received effective multidrug-resistant/rifampicin-resistant tuberculosis treatment regimens had positive outcomes with no major negative impacts on their infants, researchers reported.

The burden of age-related comorbidities was greater in women compared with men, particularly among those with HIV, a recent study in JAMA Network Open found.

The prevalence of maternal hepatitis C virus infection has significantly increased in the U.S. since the start of the opioid epidemic in 1998, according to results from a cross-sectional study published in JAMA Network Open.

Pregnant women who received an investigational group B streptococcus vaccine in a phase 2 trial transferred antibodies to their infants “at levels associated with a reduced risk of invasive group B streptococcal disease,” researchers found.

One dose of the 9-valent HPV vaccine generated a sustained immune response against two prominent cancer-causing types of the virus for up to 2 years, according study findings published in Pediatrics.

Last month, Pfizer announced that it was facing a “limited supply and impending stock out” for two of its injectable penicillin products, in part because of a surge in syphilis infections.

A Texas health system moderately increased adherence to syphilis testing among pregnant people by implementing a tool that interrupted the completion of a chart if a test was not ordered, according to findings presented at ASM Microbe.

Journey Medical Corporation announced positive, topline results from its phase 1 clinical trial evaluating the impact of DFD-29 on the microbial flora of healthy adults, according to a company press release.

A recent study of trends in HPV vaccine hesitancy found that the number of parents citing safety concerns as a reason not to vaccinate their children has increased.

Bacterial vaginosis is associated with higher rates of chlamydia persistence vs. spontaneous clearing, the Longitudinal Study of Vaginal Flora showed.